ARMSTRONG SHAW ASSOCIATES INC/CT - Q2 2018 holdings

$110 Million is the total value of ARMSTRONG SHAW ASSOCIATES INC/CT's 43 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 10.0% .

 Value Shares↓ Weighting
SYF SellSynchrony Financial$3,436,000
-1.5%
102,950
-1.0%
3.11%
-1.0%
COF SellCapital One Financial Corp.$3,357,000
-9.0%
36,534
-5.1%
3.04%
-8.6%
WMB SellWilliams Company Inc.$3,210,000
-5.0%
118,400
-12.9%
2.91%
-4.6%
HAL SellHalliburton Co.$2,538,000
-4.8%
56,317
-0.9%
2.30%
-4.4%
NXPI SellNXP Semiconductors NV$2,396,000
-6.8%
21,930
-0.2%
2.17%
-6.3%
AIG SellAmerican International Group$1,772,000
-6.3%
33,425
-3.8%
1.61%
-5.9%
AGN SellAllergan, Inc.$1,636,000
-16.4%
9,811
-15.6%
1.48%
-16.0%
WYND SellWyndham Destinations Inc.$1,204,000
-61.4%
27,195
-0.1%
1.09%
-61.2%
PNR SellPentair PLC$922,000
-42.9%
21,915
-7.5%
0.84%
-42.6%
RLGY ExitRealogy Holdings Corp$0-67,462
-100.0%
-1.66%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Apple Computer42Q3 20239.3%
Berkshire Hathaway Inc. Class A42Q3 202311.2%
UnitedHealth Group Inc.42Q3 20238.0%
Honeywell International Inc.42Q3 20235.2%
CVS Health Corp.42Q3 20235.6%
AbbVie Inc.42Q3 20234.6%
Capital One Financial Corp.42Q3 20233.8%
Chevron Corp.42Q3 20233.7%
Microsoft Corp.40Q3 202312.8%
Ameriprise Financial38Q3 20230.7%

View ARMSTRONG SHAW ASSOCIATES INC/CT's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-10-13
13F-HR2023-08-07
13F-HR2023-05-03
13F-HR2023-02-07
13F-HR2022-11-04
13F-HR2022-07-26
13F-HR2022-04-21
13F-HR2022-02-02
13F-HR2021-11-08
13F-HR2021-08-05

View ARMSTRONG SHAW ASSOCIATES INC/CT's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (110339000.0 != 110338000.0)

Export ARMSTRONG SHAW ASSOCIATES INC/CT's holdings